Medlab Clinical

Forerunners of innovation in biological medicine and research into chronic diseases and the human gut microbiome (ASX:MDC). Unique range of Nutraceuticals.

[Medlab Clinical @medlabclinical]

We are pleased to announce that the Nasal RNA program has entered the final phase of development. This is a major milestone that demonstrates the power of our NanoCelle® technology to deliver needle-free mRNA vaccines and insulin for diabetes.

https://t.co/ZvAPdkVfm6

[Medlab Clinical @medlabclinical]

Our CEO, Dr Sean Hall, had the incredible opportunity to showcase our next-generation drug delivery platform, NanoCelle®, at Jefferies London Healthcare Conference last week.

In case you missed it, a replay of the webcast is available here: https://t.co/D1imUqNsJW

[Medlab Clinical @medlabclinical]

We are excited to announce that Dr Sean Hall will be showcasing the NanoCelle® next-generation drug delivery platform at the Jefferies London Healthcare Conference - the largest healthcare-dedicated conference in Europe.

Register for the webcast here: https://t.co/D1imUqNsJW

[Medlab Clinical @medlabclinical]

Does Clinical Trials 101 have you covered? Here are some important points on why investors should pay close attention to how the research and clinical trials process works.

Our CEO and Managing Director, Dr Sean Hall, offers his perspective.

https://t.co/HqtkNMW69n

[Medlab Clinical @medlabclinical]

The cannabinoid-derived pharmaceutical sector is the fastest-growing in the entire industry.

Dr. Sean Hall, CEO of Medlab Clinical, talks about the evolution of this sector and what it will take to realise its predicted monumental growth.

https://t.co/VS2HUyJ9OS

[Medlab Clinical @medlabclinical]

Registrations closing soon, don't miss out!

[Medlab Clinical @medlabclinical]

Medlab Clinical (ASX: MDC) is working with Genetic Technologies to present a dinner designed to give investors a greater understanding of the role of Australian biotech and its potential to impact global ecosystems.

Register to attend here: https://t.co/HJlCTtypYS

[Medlab Clinical @medlabclinical]

Medlab Clinical (ASX: MDC) is working with Genetic Technologies to present a dinner designed to give investors a greater understanding of the role of Australian biotech and its potential to impact global ecosystems.

Register to attend here: https://t.co/HJlCTtypYS

[Medlab Clinical @medlabclinical]

One of the fastest-growing sectors in the entire industry is the cannabinoid-derived pharmaceutical sector.

Dr. Sean Hall, CEO of Medlab Clinical talks about the evolution of this sector and what it will take to realise its predicted monumental growth.

https://t.co/6Im7nMFdfs

[Medlab Clinical @medlabclinical]

News via @StockheadAU: Medlab Clinical Ltd reveals dual-listing ambitions to enter the U.S. Nasdaq Stock Market.

$MDC #biotech #asx #news

https://t.co/bRkldAn5JH

[Medlab Clinical @medlabclinical]

Medlab Clinical Ltd (ASX:MDC) announces: Notice of Meeting in connection with proposal to dual list to the U.S. Nasdaq Stock Market. The listing will further position Medlab as a global leader in advanced biotechnology.

Read more: https://t.co/dqlIHWl5ij

#biotechnology #nasdaq

[Medlab Clinical @medlabclinical]

Thanks to @cannabiz_au for covering the new positive results finding NanaBis to have double the bioavailability of an ARTG approved oral cannabis spray.

https://t.co/Cr2ELLqe5H

[Medlab Clinical @medlabclinical]

Researchers have confirmed that Medlab Clinical's (#ASX:MDC) lead drug candidate delivery platform, NanoCelle®, has two times more bioavailability than an ARTG approved oral cannabis medicine.

Full ASX Announcement: https://t.co/dkmmnvtB1x

#investor #ASXNews #medicine

[Medlab Clinical @medlabclinical]

Medlab Clinical Ltd (#ASX:MDC) is pleased to announce the signing of an exclusive commercial agreement for 12 products with YesHealth. For the full release: https://t.co/bKYUOle8om

#investor #ASXNews

[Medlab Clinical @medlabclinical]

Happy #ClinicalTrialsDay! Research is vital to investigate new treatments to address patients' unmet needs. We are currently recruiting participants to join 'The Medcare Study’, a cannabis-based medicine for pain study. For more info, visit: https://t.co/FL8uywE5JJ

[Medlab Clinical @medlabclinical]

NEW: Medlab has launched a new website allowing patients & doctors to access information about a #cannabis-based medicine study called The Medcare Study. Find out more at: https://t.co/FX2HZDPkL0

[Medlab Clinical @medlabclinical]

The Medlab team are excited to be heading to the United in Compassion symposium!

Professor Luis Vitetta, will be presenting on Sunday at 12:30pm, where he will discuss the 'efficacy and safety of water-soluble nanoparticle cannabis-based medicine'.

#UIC2022 #medicinalcannabis

[Medlab Clinical @medlabclinical]

Registrations closing soon, don't miss out!

[Medlab Clinical @medlabclinical]

Medlab is working with Genetic Technologies and Recce Pharmaceuticals Ltd to present a lunch designed to allow investors to become more knowledgeable in the role of biotech work happening in Australia.

Register to attend here: https://t.co/6IYCYvSXX5

[Medlab Clinical @medlabclinical]

Medicinal cannabis products are legal in Australia and are gaining in popularity due to their variety of therapeutic benefits. Australia is home to a range of effective treatments.

Read more about how to access: https://t.co/TbafZT0mSd

#medicinalcannabisaustralia

[Medlab Clinical @medlabclinical]

Medlab is working with Genetic Technologies and Recce Pharmaceuticals Ltd to present a lunch designed to allow investors to become more knowledgeable in the role of biotech work happening in Australia.

Register to attend here: https://t.co/6IYCYvSXX5

[Medlab Clinical @medlabclinical]

"What I love most... is hearing stories about the lives that have been changed" Daniel Tan, Medical Science Liaison. Watch more here: https://t.co/dCMr6iFI7L